ad image

UK Cystic Fibrosis Gene Therapy Consortium

1 / 1
Boehringer Ingelheim
Partnership

Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Imperial Innovations and Oxford Biomedica Announce New Partnership

Boehringer Ingelheim

PR-M08-18-NI-049Aug 13, 2018
1 / 1